Putnam BioRevolution ETF (SYNB)
| Assets | $2.36M |
| Expense Ratio | 0.70% |
| PE Ratio | 27.21 |
| Shares Out | 75,000 |
| Dividend (ttm) | $0.21 |
| Dividend Yield | 0.68% |
| Ex-Dividend Date | Dec 5, 2024 |
| Payout Frequency | Annual |
| Payout Ratio | 18.41% |
| Volume | 449 |
| Open | 31.61 |
| Previous Close | 31.73 |
| Day's Range | 31.61 - 31.61 |
| 52-Week Low | 24.57 |
| 52-Week High | 31.73 |
| Beta | 0.93 |
| Holdings | 5 |
| Inception Date | Sep 29, 2022 |
About SYNB
The Putnam BioRevolution ETF (SYNB) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund actively invests in companies of all sizes around the globe that enable biological innovation. SYNB was launched on Sep 29, 2022 and is issued by Putnam.
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 5, 2024 | $0.2139 | Dec 9, 2024 |
| Dec 6, 2023 | $0.0211 | Dec 11, 2023 |
Performance
SYNB had a total return of 2.48% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.85%.
News
Franklin Templeton Announces Plan to Liquidate Putnam BioRevolution™ ETF
SAN MATEO, Calif.--(BUSINESS WIRE)--Franklin Templeton today announced it will liquidate and dissolve Putnam BioRevolution™ ETF (SYNB). The liquidation is anticipated to occur on or about November 21,...
Putnam Investments Launches Fixed Income and Non-U.S. Equity Exchange-Traded Funds
BOSTON--(BUSINESS WIRE)--Putnam Investments today announced that it has officially launched five new transparent, actively managed exchange-traded funds (ETFs) that begin trading today on the New Yo...
Putnam Investments to Launch Two Innovative Active ETFs
BOSTON--(BUSINESS WIRE)--On Friday, September 30, Putnam Investments will begin to offer two new transparent, actively managed, equity exchange-traded funds (ETFs). The firm will be launching Putnam B...